Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:SPGI
NYSE:SPGICapital Markets

S&P Global Mobility Investor Day Puts Planned Spin Off In Focus

S&P Global (NYSE:SPGI) announced that its Mobility division will host its first Investor Day ahead of a planned separation into a standalone public company. The event will feature leadership presentations on the division's strategy and financial framework as part of the confirmed separation timeline. The planned spin off marks a structural change in S&P Global's business, creating a separate, focused entity in the Mobility data and insights space. S&P Global operates across indices,...
NYSE:HD
NYSE:HDSpecialty Retail

Home Depot (HD) Valuation Check After Recent Share Price Pullback And Pro Xtra Growth Narrative

Home Depot stock performance and recent moves Home Depot (HD) has drawn fresh attention as its share price now sits at $321.65, with negative returns over the past month and the past 3 months putting recent performance in focus for investors. See our latest analysis for Home Depot. Looking beyond the recent 14.36% 1 month share price decline, Home Depot’s 1 year total shareholder return of a 7.92% loss contrasts with its 3 and 5 year total shareholder returns of 17.56% and 18.10%, suggesting...
NYSE:GL
NYSE:GLInsurance

Globe Life (GL) Valuation Check After Recent Share Price Weakness And Reinsurance Cash Flow Plan

Globe Life stock in focus Globe Life (GL) is back on investors’ radar after recent share price moves, with the stock closing at US$135.11 and shorter term returns showing mixed performance over the past week and month. See our latest analysis for Globe Life. Recent share price returns have been soft, with a 6.27% 1 month share price decline and a 2.39% year to date share price decline. Longer term total shareholder returns of 4.97% over 1 year and 42.48% over 5 years point to steadier...
NYSE:OXM
NYSE:OXMLuxury

Oxford Industries (OXM) Posts Q4 Loss That Tests Bullish Turnaround Narratives

Oxford Industries (OXM) has just posted full year 2026 numbers that show fourth quarter revenue of US$374.5 million and a net loss of US$7.1 million, with basic EPS at a loss of US$0.48. Trailing 12 month revenue sits at about US$1.48 billion against a trailing net loss of US$27.9 million and loss per share of US$1.86. Over recent quarters, total revenue has moved between US$307.3 million and US$403.1 million, while quarterly basic EPS has ranged from a profit of US$1.72 to a loss of US$4.28...
NasdaqGS:CRUS
NasdaqGS:CRUSSemiconductor

Cirrus Logic (CRUS) Valuation Check After Recent Momentum And Conflicting Fair Value Signals

Cirrus Logic (CRUS) has drawn investor attention after recent share price moves, with the stock roughly flat over the past month but showing a gain of about 19% over the past 3 months. See our latest analysis for Cirrus Logic. Looking beyond the recent pullback, Cirrus Logic’s 7 day share price return of 5.38% and 90 day share price return of 18.63% sit alongside a 1 year total shareholder return of 44.10%. This suggests that momentum has been building over time. If you are interested in...
BIT:TRN
BIT:TRNElectric Utilities

Terna (BIT:TRN) Margin Slippage Tests Bullish Profitability Narratives After FY 2025 Results

Terna (BIT:TRN) has just posted another solid set of FY 2025 numbers, with third quarter revenue of €988.1 million and net income of €265 million framing the latest step in its current earnings run. The company has seen quarterly revenue move from €893 million in the third quarter of 2024 to €988.1 million in the same period of 2025, while trailing 12 month net income sits at €1.1 billion against €1.0 billion a year earlier. This sets up a story of steady top line and earnings expansion even...
ENXTPA:DBV
ENXTPA:DBVBiotechs

DBV Technologies (ENXTPA:DBV) Quarterly Loss Of US$33.2m Reinforces Bearish Profitability Narratives

DBV Technologies (ENXTPA:DBV) has put fresh numbers on the table for FY 2025, with third quarter revenue of US$2.8 million and a basic EPS loss of US$0.24 alongside a net income loss of US$33.2 million. Together, these figures provide a clear snapshot of where the business stands today. Over recent quarters, the company has reported revenue of US$0.5 million in Q4 2024, US$0.8 million in Q1 2025, US$1.5 million in Q2 2025 and US$2.8 million in Q3 2025. Over the same period, quarterly EPS has...
NasdaqGS:BHF
NasdaqGS:BHFInsurance

A Look At Brighthouse Financial (BHF) Valuation After Recent Share Price Weakness

Brighthouse Financial (BHF) is back on investors’ radar after a recent share move. The stock is trading around $59.98, with performance over the past month and past 3 months in focus. See our latest analysis for Brighthouse Financial. Recent price action has softened, with a 90 day share price return of a 7.51% decline and a year to date share price return of a 7.11% decline. However, the 1 year total shareholder return of 4.22% and 3 year total shareholder return of 35.98% indicate that...
ASX:BTR
ASX:BTRMetals and Mining

A Look At Brightstar Resources (ASX:BTR) Valuation After 2026 Earnings Downgrade And Strong Revenue Growth Outlook

Why Brightstar Resources (ASX:BTR) Is Back On Investors’ Radar Brightstar Resources (ASX:BTR) has drawn fresh attention after analysts cut earnings and revenue forecasts for 2026, now expecting a loss, even as projections still point to strong revenue growth versus sector peers. See our latest analysis for Brightstar Resources. Brightstar’s 7 day share price return of 4.41% comes after a recent A$175m follow on equity offering and analyst forecast downgrades. However, the 30 day share price...
ENXTAM:AGN
ENXTAM:AGNInsurance

Aegon (ENXTAM:AGN) Earnings Margin Surge Challenges Cautious Long Term Profitability Narratives

Aegon (ENXTAM:AGN) has just released its FY 2025 numbers, reporting second half revenue of €2.9 billion, basic EPS of €0.24 and net income of €362 million, set against trailing twelve month EPS of €0.59 and net income of €927 million. The company has seen revenue move from €6.4 billion and EPS of €0.44 in the second half of 2024 to €6.7 billion and EPS of €0.36 in the first half of 2025. Over the same period, trailing twelve month revenue has shifted from €12.8 billion with EPS of €0.37 to...
NasdaqGS:MRX
NasdaqGS:MRXCapital Markets

A Look At Marex Group (MRX) Valuation As Q1 2026 Revenue Guidance Lifts Investor Interest

Q1 2026 revenue guidance and annual filing set the scene Marex Group (MRX) has put fresh numbers on the table, guiding Q1 2026 revenue to US$667 million to US$697 million, compared with US$467 million in Q1 2025, alongside filing its 2025 annual report. See our latest analysis for Marex Group. The guidance appears to have caught investors’ attention, with Marex Group’s 1-day share price return of 5.94% and 7-day share price return of 21.48% lifting the stock to US$42.96. The 1-year total...
SEHK:100
SEHK:100Software

Assessing MiniMax Group’s Valuation After Strong Recent Share Price Momentum

MiniMax Group’s recent trading move and business snapshot MiniMax Group (SEHK:100) has drawn attention after a recent share price move, with a month return of 31.39% and 1 day and 7 day returns of 0.41% and 1.88% decline respectively. The company, founded in 2022 and based in George Town, Cayman Islands, designs and develops an artificial intelligence foundation model across text, audio, images, video, and music. See our latest analysis for MiniMax Group. MiniMax Group’s recent momentum is...
NasdaqGS:LRCX
NasdaqGS:LRCXSemiconductor

Assessing Lam Research (LRCX) Valuation After Recent Share Price Pullback

What recent performance suggests about Lam Research stock Lam Research (LRCX) has seen mixed share performance recently, with a 0.1% decline over the past day and a 7.4% drop over the past week, alongside a 15.3% pullback over the past month. That shorter term weakness sits against much stronger longer term returns. Total shareholder return has been around 193% over the past year and roughly 3.1x over three years. This has prompted fresh attention on whether the current US$211.41 price still...
TSX:SGD
TSX:SGDMetals and Mining

The Bull Case For Snowline Gold (TSX:SGD) Could Change Following Wider 2025 Losses And Rising Shares

Snowline Gold Corp. has released its full-year 2025 results, reporting a net loss of C$54.18 million, compared with C$31.23 million a year earlier, and a basic and diluted loss per share of C$0.33 versus C$0.20 previously. The widening loss highlights how the company’s spending and operational profile have changed over the past year, sharpening investor focus on its path to improved financial performance. With Snowline Gold’s higher full-year loss and recent share price gains, we’ll explore...
NYSE:EL
NYSE:ELPersonal Products

Estée Lauder Weighs Puig Tie Up And India Push In Turnaround

Estée Lauder Companies (NYSE:EL) has confirmed discussions about a potential business combination with Puig that could create one of the largest listed beauty firms globally. The company has also agreed to acquire the remaining interests in Indian luxury beauty brand Forest Essentials, moving toward full ownership. These developments arrive while Estée Lauder works through ongoing turnaround efforts and reassesses its global footprint. For shareholders watching NYSE:EL at a current share...
NasdaqGS:ITRI
NasdaqGS:ITRIElectronic

Can Itron (ITRI) Turn New AI Grid Partnerships Into a Durable Software-Led Moat?

In March 2026, Itron, Inc. expanded its grid solutions footprint by supporting Ausgrid’s rollout of the IntelliFLEX LV DERMS platform in Australia and deepening its AI-powered distributed intelligence collaboration with NVIDIA for real-time grid-edge monitoring and anomaly detection. Together, these moves highlight Itron’s push toward higher-value software, analytics, and grid management capabilities that address increasingly complex reliability and safety needs for utilities. We’ll now...
TASE:DIFI
TASE:DIFIConsumer Finance

Direct Finance of Direct Group 2006 TASE DIFI Margin Improvement Challenges Bearish Earnings Narratives

Direct Finance of Direct Group (2006) (TASE:DIFI) has just put fresh numbers on the table, with Q3 FY 2025 revenue of ₪134.6 million, basic EPS of ₪22.55 and net income of ₪60.2 million, alongside a trailing 12 month EPS of ₪43.66 and net profit margin of 16.7% compared with 14.8% a year ago. Over recent quarters the company has seen revenue move from ₪147.9 million in Q3 2024 to ₪134.6 million in Q3 2025, while basic EPS across reported periods ranged from ₪9.15 in Q2 2024 to ₪22.55 in Q3...
NasdaqGS:ASML
NasdaqGS:ASMLSemiconductor

Is It Too Late To Consider ASML Holding (NasdaqGS:ASML) After 94% One-Year Surge?

Wondering if ASML Holding at around US$1,302 a share still offers value or if the easy gains are behind it? This article walks through the numbers so you can judge that for yourself. The stock has returned 11.9% year to date, 94.5% over the last year, and 112.7% over five years, but it has also seen a 1.1% pullback over the last week and a 14.7% decline over the last month. These recent moves come against a backdrop of ongoing attention on ASML Holding as a key supplier to the semiconductor...
TSX:HBM
TSX:HBMMetals and Mining

Hudbay Minerals (TSX:HBM) Is Up 9.1% After Extending Multi-Year Copper Production Guidance Visibility – Has The Bull Case Changed?

Earlier this week, Hudbay Minerals Inc. reaffirmed its 2026 production guidance and issued new output forecasts for 2027 and 2028 across copper, gold, zinc, silver, and molybdenum. This updated multi-year production profile gives investors clearer visibility on expected volumes from Hudbay’s key assets, highlighting management’s confidence in operational continuity. Next, we’ll explore how this extended production guidance, especially the higher copper outlook, affects Hudbay Minerals’...
NasdaqGM:TMDX
NasdaqGM:TMDXMedical Equipment

TransMedics Group (TMDX) Is Down 13.0% After ENHANCE Heart IDE Approval And Platform Expansion - Has The Bull Case Changed?

Earlier in 2026, TransMedics Group reported US$727–US$757 million in 2026 revenue guidance, a higher operating margin of 13% in the latest quarter, and secured full FDA IDE approval for its ENHANCE Heart trial as it expands its National OCS Program to nearly 30% of U.S. transplant procedures. Beyond device sales, TransMedics is moving toward a vertically integrated transplant platform that could become embedded in the federal transplant ecosystem by 2027, potentially reshaping how multiple...
TASE:RANI
TASE:RANIReal Estate

Rani Zim Shopping Centers (TASE:RANI) Margin Compression Reinforces Bearish Earnings Narratives

Rani Zim Shopping Centers (TASE:RANI) has released its FY 2025 figures, with the latest quarter showing revenue of ₪43.8m and net income of ₪9.1m, equal to EPS of ₪0.05. The trailing 12 months reflect a net profit margin of 15.4% compared with 47.3% a year earlier. Over recent quarters the company has seen revenue move from ₪66.8m in Q3 2024 to ₪56.3m in Q1 2025, then to ₪101.0m in Q2 2025 and ₪43.8m in Q3 2025. EPS shifted from ₪0.59 to a loss of ₪0.06, then ₪0.16 and ₪0.05, as a one-off...
NYSE:GME
NYSE:GMESpecialty Retail

A Look At GameStop (GME) Valuation As Recent Momentum Cools And Narratives Diverge

GameStop (GME) remains in focus for retail investors after recent trading volatility, with the stock last closing at US$22.10. Recent returns show a 2% decline over the past week and a 9% decline over the past month. See our latest analysis for GameStop. The recent 2% 7 day share price return and 9% 30 day share price return contrast with a 7.2% year to date share price return and a modest 2.9% 1 year total shareholder return. This suggests that momentum has cooled after earlier gains. If you...
NYSE:ORCL
NYSE:ORCLSoftware

Oracle Nashville Expansion And Veritone Deal Feed Cloud And AI Thesis

Oracle (NYSE:ORCL) has signed a major office lease in Nashville to support thousands of new tech jobs. The expanded presence is intended to make Nashville a key hub for cloud and AI work within Oracle. Oracle also entered a multi year agreement to host Veritone's AI platforms on Oracle Cloud Infrastructure. The partnership brings Veritone's AI solutions onto Oracle's cloud to serve customers across multiple industries. For investors watching Oracle's cloud and AI initiatives, the Nashville...
NasdaqGS:ONC
NasdaqGS:ONCBiotechs

Assessing BeOne Medicines (ONC) Valuation After Recent Share Price Volatility

BeOne Medicines overview BeOne Medicines (ONC) has drawn investor attention after a recent period of mixed share performance, including a 2.2% move over the past day alongside declines over the past month and past 3 months. See our latest analysis for BeOne Medicines. The recent 2.2% 1 day share price gain to around $283.03 comes after a weaker 30 day share price return of a 19.65% decline. The 1 year total shareholder return of 5.85% and 3 year total shareholder return of 31.32% suggest...